aluates Reports

$ 0.0

Automative

Deuterated Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: November 2024

Report Code: QYRE-Auto-23B9776

Global Deuterated Drugs Market Size Status and Forecast 2022 2028

BUY CHAPTERS

Deuterated Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23B9776

Report

November 2024

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

TEVA

Suzhou Zelgen Biopharmaceuticals

Concert Pharmaceuticals

Vertex Pharmaceuticals

Hinova Pharma

Otsuka Pharmaceutical (Avanir)

Poxel SA (DeuteRx)

Deuterated Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Deuterated Drugs - Market

A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.

The global market for Deuterated Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Deuterated Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Deuterated Drugs by region & country, by Type, and by Application.

The Deuterated Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deuterated Drugs.

Market Segmentation

Scope of Deuterated Drugs - Market Report

Report Metric	Details
Report Name	Deuterated Drugs - Market
CAGR	5%
Segment by Type:	Austedo Zepsun Others
Segment by Application	Huntington'S Disease (HD) Tardive Dyskinesia (TD) Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir), Poxel SA (DeuteRx)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Deuterated Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Deuterated Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Deuterated Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Deuterated Drugs - Market report?

Ans: The main players in the Deuterated Drugs - Market are Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir), Poxel SA (DeuteRx)

What are the Application segmentation covered in the Deuterated Drugs - Market report?

Ans: The Applications covered in the Deuterated Drugs - Market report are Huntington'S Disease (HD), Tardive Dyskinesia (TD), Cancer, Others

What are the Type segmentation covered in the Deuterated Drugs - Market report?

Ans: The Types covered in the Deuterated Drugs - Market report are Austedo, Zepsun, Others

Recommended Reports

Prescription & Generic Drugs

Drug Development Services

Therapeutic Drug Classes

1 Market Overview

1.1 Deuterated Drugs Product Introduction

1.2 Global Deuterated Drugs Market Size Forecast

1.3 Deuterated Drugs Market Trends & Drivers

1.3.1 Deuterated Drugs Industry Trends

1.3.2 Deuterated Drugs Market Drivers & Opportunity

1.3.3 Deuterated Drugs Market Challenges

1.3.4 Deuterated Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Deuterated Drugs Players Revenue Ranking (2023)

2.2 Global Deuterated Drugs Revenue by Company (2019-2024)

2.3 Key Companies Deuterated Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Deuterated Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Deuterated Drugs

2.6 Deuterated Drugs Market Competitive Analysis

2.6.1 Deuterated Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Deuterated Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Austedo

3.1.2 Zepsun

3.1.3 Others

3.2 Global Deuterated Drugs Sales Value by Type

3.2.1 Global Deuterated Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Deuterated Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Deuterated Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Huntington'S Disease (HD)

4.1.2 Tardive Dyskinesia (TD)

4.1.3 Cancer

4.1.4 Others

4.2 Global Deuterated Drugs Sales Value by Application

4.2.1 Global Deuterated Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Deuterated Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Deuterated Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Deuterated Drugs Sales Value by Region

5.1.1 Global Deuterated Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Deuterated Drugs Sales Value by Region (2019-2024)

5.1.3 Global Deuterated Drugs Sales Value by Region (2025-2030)

5.1.4 Global Deuterated Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Deuterated Drugs Sales Value, 2019-2030

5.2.2 North America Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Deuterated Drugs Sales Value, 2019-2030

5.3.2 Europe Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Deuterated Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Deuterated Drugs Sales Value, 2019-2030

5.5.2 South America Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Deuterated Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Deuterated Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Deuterated Drugs Sales Value

6.3 United States

6.3.1 United States Deuterated Drugs Sales Value, 2019-2030

6.3.2 United States Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Deuterated Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Deuterated Drugs Sales Value, 2019-2030

6.4.2 Europe Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Deuterated Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Deuterated Drugs Sales Value, 2019-2030

6.5.2 China Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Deuterated Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Deuterated Drugs Sales Value, 2019-2030

6.6.2 Japan Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Deuterated Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Deuterated Drugs Sales Value, 2019-2030

6.7.2 South Korea Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Deuterated Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Deuterated Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Deuterated Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Deuterated Drugs Sales Value, 2019-2030

6.9.2 India Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Deuterated Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Teva

7.1.1 Teva Profile

7.1.2 Teva Main Business

7.1.3 Teva Deuterated Drugs Products, Services and Solutions

7.1.4 Teva Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 Teva Recent Developments

7.2 Suzhou Zelgen Biopharmaceuticals

7.2.1 Suzhou Zelgen Biopharmaceuticals Profile

7.2.2 Suzhou Zelgen Biopharmaceuticals Main Business

7.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Products, Services and Solutions

7.2.4 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments

7.3 Concert Pharmaceuticals

7.3.1 Concert Pharmaceuticals Profile

7.3.2 Concert Pharmaceuticals Main Business

7.3.3 Concert Pharmaceuticals Deuterated Drugs Products, Services and Solutions

7.3.4 Concert Pharmaceuticals Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 Vertex Pharmaceuticals Recent Developments

7.4 Vertex Pharmaceuticals

7.4.1 Vertex Pharmaceuticals Profile

7.4.2 Vertex Pharmaceuticals Main Business

7.4.3 Vertex Pharmaceuticals Deuterated Drugs Products, Services and Solutions

7.4.4 Vertex Pharmaceuticals Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 Vertex Pharmaceuticals Recent Developments

7.5 Hinova Pharma

7.5.1 Hinova Pharma Profile

7.5.2 Hinova Pharma Main Business

7.5.3 Hinova Pharma Deuterated Drugs Products, Services and Solutions

7.5.4 Hinova Pharma Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Hinova Pharma Recent Developments

7.6 Otsuka Pharmaceutical (Avanir)

7.6.1 Otsuka Pharmaceutical (Avanir) Profile

7.6.2 Otsuka Pharmaceutical (Avanir) Main Business

7.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Products, Services and Solutions

7.6.4 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 Otsuka Pharmaceutical (Avanir) Recent Developments

7.7 Poxel SA (DeuteRx)

7.7.1 Poxel SA (DeuteRx) Profile

7.7.2 Poxel SA (DeuteRx) Main Business

7.7.3 Poxel SA (DeuteRx) Deuterated Drugs Products, Services and Solutions

7.7.4 Poxel SA (DeuteRx) Deuterated Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 Poxel SA (DeuteRx) Recent Developments

8 Industry Chain Analysis

8.1 Deuterated Drugs Industrial Chain

8.2 Deuterated Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Deuterated Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Deuterated Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

TEVA

Suzhou Zelgen Biopharmaceuticals

Concert Pharmaceuticals

Vertex Pharmaceuticals

Hinova Pharma

Otsuka Pharmaceutical (Avanir)

Poxel SA (DeuteRx)

List of Tables

Table 1. Deuterated Drugs Market Trends

Table 2. Deuterated Drugs Market Drivers & Opportunity

Table 3. Deuterated Drugs Market Challenges

Table 4. Deuterated Drugs Market Restraints

Table 5. Global Deuterated Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Deuterated Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Deuterated Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Deuterated Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Deuterated Drugs

Table 10. Global Deuterated Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Deuterated Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Deuterated Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Deuterated Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Deuterated Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Deuterated Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Deuterated Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Deuterated Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Deuterated Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Deuterated Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Deuterated Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Deuterated Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Deuterated Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Deuterated Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Deuterated Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Deuterated Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Deuterated Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Deuterated Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Deuterated Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. Teva Basic Information List

Table 32. Teva Description and Business Overview

Table 33. Teva Deuterated Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Deuterated Drugs Business of Teva (2019-2024)

Table 35. Teva Recent Developments

Table 36. Suzhou Zelgen Biopharmaceuticals Basic Information List

Table 37. Suzhou Zelgen Biopharmaceuticals Description and Business Overview

Table 38. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Deuterated Drugs Business of Suzhou Zelgen Biopharmaceuticals (2019-2024)

Table 40. Suzhou Zelgen Biopharmaceuticals Recent Developments

Table 41. Concert Pharmaceuticals Basic Information List

Table 42. Concert Pharmaceuticals Description and Business Overview

Table 43. Concert Pharmaceuticals Deuterated Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Deuterated Drugs Business of Concert Pharmaceuticals (2019-2024)

Table 45. Concert Pharmaceuticals Recent Developments

Table 46. Vertex Pharmaceuticals Basic Information List

Table 47. Vertex Pharmaceuticals Description and Business Overview

Table 48. Vertex Pharmaceuticals Deuterated Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Deuterated Drugs Business of Vertex Pharmaceuticals (2019-2024)

Table 50. Vertex Pharmaceuticals Recent Developments

Table 51. Hinova Pharma Basic Information List

Table 52. Hinova Pharma Description and Business Overview

Table 53. Hinova Pharma Deuterated Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Deuterated Drugs Business of Hinova Pharma (2019-2024)

Table 55. Hinova Pharma Recent Developments

Table 56. Otsuka Pharmaceutical (Avanir) Basic Information List

Table 57. Otsuka Pharmaceutical (Avanir) Description and Business Overview

Table 58. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Deuterated Drugs Business of Otsuka Pharmaceutical (Avanir) (2019-2024)

Table 60. Otsuka Pharmaceutical (Avanir) Recent Developments

Table 61. Poxel SA (DeuteRx) Basic Information List

Table 62. Poxel SA (DeuteRx) Description and Business Overview

Table 63. Poxel SA (DeuteRx) Deuterated Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Deuterated Drugs Business of Poxel SA (DeuteRx) (2019-2024)

Table 65. Poxel SA (DeuteRx) Recent Developments

Table 66. Key Raw Materials Lists

Table 67. Raw Materials Key Suppliers Lists

Table 68. Deuterated Drugs Downstream Customers

Table 69. Deuterated Drugs Distributors List

Table 70. Research Programs/Design for This Report

Table 71. Key Data Information from Secondary Sources

Table 72. Key Data Information from Primary Sources

Table 73. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Deuterated Drugs Product Picture

Figure 2. Global Deuterated Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Deuterated Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Deuterated Drugs Report Years Considered

Figure 5. Global Deuterated Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Deuterated Drugs Revenue in 2023

Figure 7. Deuterated Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Austedo Picture

Figure 9. Zepsun Picture

Figure 10. Others Picture

Figure 11. Global Deuterated Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Deuterated Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Huntington'S Disease (HD)

Figure 14. Product Picture of Tardive Dyskinesia (TD)

Figure 15. Product Picture of Cancer

Figure 16. Product Picture of Others

Figure 17. Global Deuterated Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Deuterated Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Deuterated Drugs Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Deuterated Drugs Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Deuterated Drugs Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Deuterated Drugs Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Deuterated Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Deuterated Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Deuterated Drugs Sales Value (%), (2019-2030)

Figure 30. United States Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 36. China Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 38. China Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 48. India Deuterated Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Deuterated Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. India Deuterated Drugs Sales Value by Application (%), 2023 VS 2030

Figure 51. Deuterated Drugs Industrial Chain

Figure 52. Deuterated Drugs Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Deuterium substituteddrugs Market

Global Deuterium and Tritium Market Research Report 2025

Global Deuterated Solvents Market Research Report 2024

Deuterium Lamps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Deuterium Water Market Research Report 2025

Global Deuterated Chloroform Market Research Report 2025

Global Deuterated Reagents for Electronics Market Research Report 2025

Global High Purity Deuterium Element Market Research Report 2025

Nuclear Medicine Isotopes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Deuterated NMR Solvents Market Insights Forecast to 2030

Difluprednate Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Deuterated Silane Market Research Report 2024

Global Isotope Market Research Report 2024

Global High Purity Deuterium Gas Market Research Report 2025

2 Deoxy D Glucose Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Deuterated Compounds Market Research Report 2025

Global Deuterium Labeled Compounds Market Research Report 2024

Global Deuterium Dimethyl Sulfoxide Market Research Report 2024

Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stable Isotope Labelled Compounds Market Research Report 2024

RELATED REPORTS

Global Robotics Paint Booth Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3R7922

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Civil Engineering Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20Y6111

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Humanoid Robot Bearings Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12J17457

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global CAD in Industrial Machinery Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32J5952

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions